Cannabis Bioscience International Holdings (CBIH) Total Current Liabilities (2023 - 2026)

Cannabis Bioscience International Holdings has disclosed Total Current Liabilities across 4 years of filings, most recently posting $1.2 million for Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $1.2 million, up 25.68% year-over-year; the trailing twelve-month figure through Feb 2026 was $1.2 million (up 25.68% YoY), and the FY2025 annual result was $945963.0, up 7.26% from the prior year.
• Total Current Liabilities came in at $1.2 million for Q1 2026 at Cannabis Bioscience International Holdings, up from $1.1 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $1.2 million in Q1 2026 to a low of $385547.0 in Q2 2023.
• The 4-year median for Total Current Liabilities is $881909.0 (2024), against an average of $885479.5.
• Across the five-year window, Total Current Liabilities soared 128.74% in 2024 and rose 7.26% in 2025, its largest moves.
• Cannabis Bioscience International Holdings' Total Current Liabilities stood at $660307.0 in 2023, then surged by 32.16% to $872674.0 in 2024, then surged by 30.15% to $1.1 million in 2025, then gained by 7.34% to $1.2 million in 2026.
• The last three Total Current Liabilities figures came in at $1.2 million (Q1 2026), $1.1 million (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.